Skip to content

UNIGENE LABORATORIES INC: 10-K/A filed 2013-01-31

What UNIGENE LABORATORIES INC reported in its annual report amendment filed 2013-01-31 (fiscal FY 2011): 36 published measures, 93 facts as tagged in accession 0001437749-13-000964.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-K/A (annual report amendment)
Filed
2013-01-31
Fiscal period
fiscal FY 2011
Accession
0001437749-13-000964 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All UNIGENE LABORATORIES INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-3118,195,169USD
At 2010-12-3129,211,753USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-12-3183,892,333USD
At 2010-12-3191,029,926USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-31-65,697,164USD
At 2010-12-31-61,818,173USD
At 2009-12-31-30,441,661USD
At 2008-12-31-18,972,458USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-12-314,681,683USD
At 2010-12-3112,200,800USD
At 2009-12-314,894,210USD
At 2008-12-318,583,226USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-7,095,558USD365
2010-01-01 to 2010-12-31-32,533,951USD365
2009-01-01 to 2009-12-31-13,379,679USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-6,766,376USD365
2010-01-01 to 2010-12-31-1,668,521USD365
2009-01-01 to 2009-12-31-11,290,774USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-12-31694,600USD365
2010-01-01 to 2010-12-31144,478USD365
2009-01-01 to 2009-12-31220,055USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-01-01 to 2011-12-3120,508,346USD365
2010-01-01 to 2010-12-3111,340,214USD365
2009-01-01 to 2009-12-3112,791,838USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,920,423USD365
2010-01-01 to 2010-12-319,653,608USD365
2009-01-01 to 2009-12-314,571,551USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-2,673,164USD365
2010-01-01 to 2010-12-31-678,497USD365
2009-01-01 to 2009-12-313,030,207USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-12-31-182,341,278USD
At 2010-12-31-175,245,720USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-01-01 to 2011-12-3193,181,384shares365
2010-01-01 to 2010-12-3191,961,673shares365
2009-01-01 to 2009-12-3190,662,089shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-0.08USD/shares365
2010-01-01 to 2010-12-31-0.35USD/shares365
2009-01-01 to 2009-12-31-0.15USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-601,070USD365
2010-01-01 to 2010-12-31-700,503USD365
2009-01-01 to 2009-12-31-67,115USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-12-312,977,058USD
At 2010-12-313,190,117USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,296,144USD365
2010-01-01 to 2010-12-311,086,009USD365
2009-01-01 to 2009-12-31614,805USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-3,466,229USD365
2010-01-01 to 2010-12-31-10,323,927USD365
2009-01-01 to 2009-12-31-12,379,514USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-3110,290,225USD
At 2010-12-3116,058,038USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-01-01 to 2011-12-3110,483,866USD365
2010-01-01 to 2010-12-318,038,525USD365
2009-01-01 to 2009-12-314,862,319USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-315,696,756USD
At 2010-12-317,300,259USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-12-311,472,925USD
At 2010-12-31974,998USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-12-312,854,038USD
At 2010-12-311,553,091USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-01-01 to 2011-12-3123,974,575USD365
2010-01-01 to 2010-12-3121,664,141USD365
2009-01-01 to 2009-12-3125,171,352USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-12-311,283,550USD
At 2010-12-311,417,934USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2011-01-01 to 2011-12-318,887,010USD365
2010-01-01 to 2010-12-317,685,039USD365
2009-01-01 to 2009-12-318,937,683USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-01-01 to 2011-12-319,015,749USD365
2010-01-01 to 2010-12-316,428,041USD365
2009-01-01 to 2009-12-3112,350,796USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-3195,215,599shares
At 2010-12-3192,448,947shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-12-31115,691,958USD
At 2010-12-31112,503,058USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2011-12-312,020,458USD
At 2010-12-312,670,044USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-12-31341,014USD
At 2010-12-31313,382USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-12-316,101,287USD
At 2010-12-3111,152,037USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-12-312,094,449USD
At 2010-12-312,834,345USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-7,696,628USD365
2010-01-01 to 2010-12-31-33,234,454USD365
2009-01-01 to 2009-12-31-13,446,794USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-01-01 to 2011-12-31709,588USD365
2010-01-01 to 2010-12-31965,008USD365
2009-01-01 to 2009-12-31732,464USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,500,000USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-1,069,717USD365
2010-01-01 to 2010-12-31-1,905,777USD365
2009-01-01 to 2009-12-312,092,971USD365

Inspect the source

Entity
UNIGENE LABORATORIES INC / CIK 0000352747
Captured
SEC response SHA-256
b5f82fa201083b12be312039e3ed1f63c9fd8fc7c8ed9d7ce87dfd8eeb9db641

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000352747.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))